Sickle cell anaemia (SCA) is a genetic disorder which can be complicated by haemolytic, vasoocclusive and thrombotic processes. Antithrombin III (ATIII) is a naturally occurring anticoagulant with anti inflammatory properties. The objective of this study was to determine the level of ATIII in individuals with SCA and to assess its role in vaso-occlusive crisis. This was an observational cross sectional study in which 60 adult HbSS (34 in steady state and 26 in vaso-occlusive crisis) subjects and 60 apparently healthy adults matched for sex and age served as controls. Haemoglobin (Hb) electrophoresis of subjects and controls was determined using Hb electrophoresis. Nine and a half (9.5) milliliters of blood, divided into two aliquots of 4.5mls (in 0.5mls of tri sodium citrate for coagulation studies) and 5mls (in EDTA containing bottle for full blood count) was obtained. Quantitative assessment of antithrombin III by chromogenic assay with Factor Xa was carried out using Diachrom ATIII test kit. Prothrombin time(PT), activated partial thromboplastin time(APTT), haematocrit, total white blood cells (WBC) and platelets count were assessed using standard protocol. SPSS (version 13 for windows) was used for data analysis. A p value of <0.05 was considered significant. The subjects were made up of 33(55%) males and 27(45%) females, with a mean age of 22.52(5.21) years whilst the controls consisted of 34(56.7%) males and 26(43.3%) females with a mean age of 22.85 (4.20). HbS subjects had a significantly lower ATIII levels compared with controls (p=0.009). Levels of ATIII that was found in SCA patients in steady state and in vaso-occlusive crisis did not differ significantly (p=0.468). Haematocrit was significantly lower in HbS than controls (p=0.000), whereas total WBC count (p=0.000), absolute platelet count (p=0.003), and Prothrombin time (0.008) were significantly higher in the HbS subjects. ATIII levels did not differ significantly between steady state and vasoocclusive crisis, suggesting that ATIII does not play an active role in pathogenesis of vasoocclusive crisis.
INTRODUCTION
Antithrombin (ATIII) is one of the most important endogenous regulators of coagulation, acting as the major inhibitor of thrombin and interfering with several plasma proteases such as Kallikren and Factors IXa, Xa, XIa and XIIa. Aside from its anticoagulant role, ATIII exhibits a myriad of antiinflammatory effects including inhibition of neutrophil migration and adhesion; prevention of leukocyteendothelial interaction; amelioration of ischemic/reperfusion injury; attenuation of cytokine production in monocyte and endothelial cells. 1, 2, 3 The anticoagulant and anti inflammatory properties of ATIII makes it an important molecule to study, given the intimate link between coagulation and inflammation on the pathophysiologic processes of SCA. 4 Notwithstanding that a single amino acid substitution underlies the molecular basis of SCA, the evolution of the corresponding disease is extra ordinarily complicated and involves multiple pathogenic factors such as activation of the endothelium, disordered vasoregulation and activation of the coagulation system. 4 Every component of haemostasis including platelet function, the procoagulant, anti-coagulant and fibrinolytic system is altered in SCA. Numerous studies have documented high levels of thrombin, abnormal activation of fibrinolysis and decreased levels of Protein C, Protein S and Anti thrombin III (ATIII), leading to the conclusions that sickle cell disease is in fact a 'Hypercoagulable state'. 4, 5 The commonest type of sickle cell disorder in Nigeria is the homozygous sickle cell disorder (HbS), also known as sickle cell anaemia (SCA). About two (2%) of all babies born to Nigerian parents have SCA, translating to over 100,000 births with the disorder annually. 6 The frequency of the heterozygous form, also known as the sickle cell trait (HbAS) determines this prevalence, and it has been established that about 25% of the entire population of Nigeria are carrying the sickle trait, making it the largest sickle cell gene pool in the world. 7, 8 Despite the high prevalence of SCA in Nigeria and the potential role of ATIII in coagulation and inflammation, there is a paucity of information on the levels of ATIII in patients with SCA. The aim of this study is to assess the level of Antithrombin III in sickle cell anaemia patients and compare it with apparently healthy, non-sickle cell anaemia individuals. The ATIII levels of HbS in steady state will also be compared to that of HbSS in crises, to ascertain if it plays a role in vaso-occlusive crisis.
METHODS

Sixty consecutive eligible HbS patients comprising 34
HbS in steady state, and 26 in vaso-occlusive were enrolled in to the study. Sixty apparently healthy adult, age and sex matched HbAA consenting individuals were recruited as controls. Heamatocrit, total white blood cells count, platelets count, prothrombin time, activated partial thromboplastin time and Antithrombin III levels were evaluated for all studied individuals.
Nine and half (9.5mls) millilitres of venous blood was obtained from the subjects and controls via the antecubital vein, adhering to standard procedures to avoid any blood activation. Exactly 4.5mls of the drawn blood was added into a plain bottle containing 0.5mls of tri-citrate sodium. This was centrifuged within the first two hours of collection at 2000g for fifteen minute. The plasma was stored at -20 o C until analysis, for Prothrombin time, activated partial thromboplastin time and ATIII estimation. The plasma was thawed for fifteen minute in a water bath at 37 o C prior to analysis. The remaining 5mls of the drawn blood was added into EDTA containing plastic bottle and inverted several times to ensure adequate mixing of the content, this was use for Full Blood Count analysis. All samples were analyzed at the Haematology and Chemical Pathology Departments of the University of Maiduguri teaching hospital.
All patients had their haematocrit, total white blood cells count and platelets count performed manually as described by Dacie and Lewis. 9 A chromogenic assay for the quantitative determination of the heparin co-factor activity of ATIII in human citrated plasma, using an anti-Xa method was employed for this study. DiaChrom ATIII test kit (batch number 307050 10.07 from DiaMed.Cressier, Switzerland) was used. Data collected were analysed using statistical package for social sciences version 13.0 (SPSS Chicago Ill. USA). Continuous variables were expressed as mean ± standard deviation (SD). Independent T-test was used to compare means of variables outcomes between the subjects and control, as well between HbS subjects in steady state and in vaso-occlusive crisis. A p value of <0.05 was considered significant
RESULTS
Comparisons of the demographic and laboratory profile of the subjects and controls are shown in table1 There was statistically significant difference between the Haematocrit (p=0.000), the total white blood cells count(p=0.000), the platelets count (p=0.003), the prothrombin time (p=0.008) and ATIII (p=0.009). The Mean activated partial thromboplastin time of the subjects was not significantly different compared with the controls (P=0.321).
Comparison of demographic and haematological variables of HbS Subjects in steady state and those in vaso-occlusive crisis are shown in table 2.There was no statistical significant difference in all the variables measured. 10 in Zaria where the profiles of SCA patients was compared to agematched controls as well as reports from other parts of the world 11, 12 The decreased level of ATIII may be partly attributed to the background inflammatory state of SCA. 4, 13 During severe inflammatory responses, ATIII is markedly reduced because of impaired synthesis resulting from negative acute phase response, degradation by elastases from activated neutrophils, and most importantly consumption as a consequence of on-going thrombin generation. 14, 15, 16 In addition, proinflammatory cytokines can also cause reduced synthesis of glycoaminoglycans (physiologic heparin like cofactors) on the endothelial surface, leading to a reduced ATIII function. 17 The findings of this study is in contrast to those of Porter and Young 18 , and Leisner et al (1998) 19 who reported normal levels of ATIII in HbSS patients. This could be due to the differences in the methods of assay used. Whereas they used the thrombin-based method, ATIII assay was done using the factor Xa method in this study. Assays based on thrombin lead to overestimation of ATIII levels because of the interference of thrombin with heparin cofactor (HCII). Heparin cofactor II inhibits thrombin, leaving most of the ATIII untreated resulting in overestimation. 20 The lack of reaction between HCII and factor Xa results in a more reliable detection of ATIII deficiency.
Normal and high levels of ATIII were documented by Babiker and Richardson respectively in different studies. 21, 22 However, subjects enrolled into aforementioned studies were of different age group compared to the population being reported in this study. The small sample size in the study by Richardson may also contribute to the discrepancy observed. 22 A number of studies have confirmed the activation of the coagulation system in SCA patients in steady state. The mechanisms include a decrease in levels of physiological anticoagulants (ATIII, Protein C and Protein S) and/or increased levels of pro-coagulant factors. 23, 24, 25 These studies did not find significant difference in the levels of ATIII between HbSS patients in steady state and those in vaso-occlusive crisis, a finding similar to that reported by Hager and Wolffs; 26 and also by Bashawi. 12 This implies that there is no further enhancement of activation of the coagulation system in vaso-occlusive crisis above that observed in steady state. Levels of other physiological anticoagulants which may also play a role did not show significant difference between steady state and vaso-occlusive crisis. 27 A decline in levels of ATIII, reaching its nadir on the third day was reported by Richardson among HbS patients having vaso-occlusive crisis. 22 However, this could be a secondary response to the stasis created by sickled erythrocytes, leading to further activation of coagulation and thrombin generation, resulting in increased consumption of ATIII. The progressive decline in ATIII reaching its lowest level on the third day suggests that rather than playing an aetiologic role in the pathogenesis of vaso-occlusive crisis, ATIII deficiency occurred as a secondary phenomenon.
The significantly increased prothrombin time observed in the HbS subjects is in keeping with the reports of Fiekumo and Shokunbi. 28 Being a hypercoagulable state, the findings of prolonged PT in SCA is rather paradoxical. However, this can be due to the low levels of factors VII and V in patients with SCA. 13, 14, 29 The similarity in levels of APTT between subjects and controls in this study is in keeping with the reports of Babiker. 21 In contrast, Fiekumo and Shokunbi 28 found prolonged APTT amongst SCA patients. This may be due to the reduced levels of factor Xa in the population they studied. There was no significant difference between the APTT of patients in steady state and those in vaso-occlusive crisis in the index study (p= 0.339).
The reduced haematocrit observed in the HbS subjects studied is similar to results of other workers. 30, 31 Reduced haematocrit has been associated with continuous haemolysis of red blood cells reducing their survival to 10-20 days, and splenic sequestration. The similarity in haematocrit of subjects in steady state and in crisis observed is supported by the findings of Omoti .
31
The total white blood cell counts of the subjects was significantly higher than those of the control group (p=0.000) in this study. This is consistent with several studies which showed that leucocytosis was a common feature of SCA even in the steady state and absence of infection. 32, 33 Akinola 34 suggested the generation of an inert inflammatory response, which lead to release of cytokine mediator, some of whose main function is increase neutrophil production by the bone marrow. There was no significant difference in the mean leukocyte of subjects in steady state and those in crisis (p= 0.770). This is similar to the finding of Omoti. The index study showed significant difference in the mean platelet count of the subjects as compared to that of the controls (p= 0.003).This result is an agreement with previous studies. 26, 27 This high count may be due to loss of splenic platelet pool function, in adult sickle cell patients consequent upon autosplenectomy. There was no significant difference between values in steady state and vaso-occlusive crisis (p=0.902).
In conclusion, this study have shown that Plasma level of ATIII was lower in HbS subject compared with their controls, however ATIII levels did not differ significantly between HbS subjects in steady state and those in vaso-occlusive crisis, suggesting that low ATIII does not play a significant role in the pathogenesis of vaso-occlusive crisis in HbS subjects; A longitudinal study with sequential assaying of ATIII in subjects during vaso-occlusive crisis through convalescence may shed more lights on the role of ATIII in the pathogenesis of vasoocclusive crisis.
